Centrosome-declustering drugs mediate a two-pronged attack on interphase and mitosis in supercentrosomal cancer cells.
about
Maintaining Genome Stability in Defiance of Mitotic DNA DamageFunctions of Aurora kinase C in meiosis and cancerDrugging the addict: non-oncogene addiction as a target for cancer therapyStat3 regulates centrosome clustering in cancer cells via Stathmin/PLK1.Prognostic value of CA20, a score based on centrosome amplification-associated genes, in breast tumors.Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancerRampant centrosome amplification underlies more aggressive disease course of triple negative breast cancersAmplified centrosomes may underlie aggressive disease course in pancreatic ductal adenocarcinoma.Turning the headlights on novel cancer biomarkers: Inspection of mechanics underlying intratumor heterogeneity14-3-3γ Prevents Centrosome Amplification and Neoplastic Progression.Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancer.New Colchicine-Derived Triazoles and Their Influence on Cytotoxicity and Microtubule Morphology.Centrosome amplification, chromosomal instability and cancer: mechanistic, clinical and therapeutic issues.Dividing with Extra Centrosomes: A Double Edged Sword for Cancer Cells.Evolving Therapeutic Strategies to Exploit Chromosome Instability in Cancer.
P2860
Q26738970-B05778F9-56EB-4466-8637-53AB95755988Q26782717-31829CBF-2567-4616-9FA6-82DB60EE6AB1Q28079559-DEBF563B-E228-456E-9340-7E3FB2EC1386Q33654342-10A61650-8615-4D4A-AE40-F65B755AE93BQ33671140-724941A7-7E9D-41B1-BF7E-5836F8FA6EA6Q33689051-854D3FC9-0561-4AF5-9CC1-510657661EFCQ35833047-7A618EC0-4DA5-4C8E-9050-2A18D4E0C853Q36189152-5D469F6E-FF2F-4883-BE60-2D5F392B8271Q36658298-13AF9F3A-FAB6-4537-BCEE-CC88878FBD6CQ36961022-D9206725-4BD0-4097-95E5-122E7FA5513DQ37565093-7F609D31-B15A-4063-B7D9-8186BB7B8FEDQ38434222-2F1DFBDD-E3BC-41D2-AE59-74E78B2BC408Q38662334-91AB2005-95E1-415E-B0F6-6423A6FAE94FQ39363632-BDFAD208-68F8-4805-BF11-CBC2A72FED30Q47119995-42F1EB76-F2BD-42C3-BB0B-AC4BC18AC4DF
P2860
Centrosome-declustering drugs mediate a two-pronged attack on interphase and mitosis in supercentrosomal cancer cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Centrosome-declustering drugs ...... supercentrosomal cancer cells.
@ast
Centrosome-declustering drugs ...... supercentrosomal cancer cells.
@en
Centrosome-declustering drugs ...... supercentrosomal cancer cells.
@nl
type
label
Centrosome-declustering drugs ...... supercentrosomal cancer cells.
@ast
Centrosome-declustering drugs ...... supercentrosomal cancer cells.
@en
Centrosome-declustering drugs ...... supercentrosomal cancer cells.
@nl
prefLabel
Centrosome-declustering drugs ...... supercentrosomal cancer cells.
@ast
Centrosome-declustering drugs ...... supercentrosomal cancer cells.
@en
Centrosome-declustering drugs ...... supercentrosomal cancer cells.
@nl
P2093
P2860
P356
P1476
Centrosome-declustering drugs ...... supercentrosomal cancer cells
@en
P2093
G Cantuaria
J Gopalakrishnan
P C G Rida
P2860
P356
10.1038/CDDIS.2014.505
P577
2014-11-20T00:00:00Z